Most gut protocols fail for one of two reasons: they reseed before they weed, or they weed and never reseed. Both leave you worse off than a well-sequenced plan would. The order is not a preference - it is the mechanism. This guide first characterizes your pattern (where the symptoms sit, when they peak, which way the bowel tips), then clears the overgrowth in Phase 1 and repairs the lining and reintroduces commensal species in Phase 2. Two phases, in order, with the timing the biology requires.
Before you begin
Is this for you?
This guide is for
- People with chronic bloating, gas, abdominal discomfort, or irregular bowel habits that haven't resolved with dietary changes alone
- Anyone with confirmed SIBO on breath testing, or a picture strongly suggestive of it - bloating that worsens across the day, distension after meals, symptoms that ease with fasting
- People whose food sensitivities keep expanding - more and more foods triggering reactions - which points to intestinal permeability, not a problem with each new food
- People with a history of frequent antibiotics, GI infections, or prolonged NSAID use that disrupted the mucosal barrier
- Anyone reading this alongside the Metabolic Derailment or Anxiousness guides - gut dysbiosis sits mechanistically upstream of both insulin resistance and stress-axis dysregulation
This guide is not for
- People with confirmed inflammatory bowel disease (Crohn's, ulcerative colitis) - these are specialist-managed conditions, and antimicrobial protocols can worsen an active flare
- Anyone with a known or suspected GI malignancy - get that ruled out before any self-directed GI protocol
- Anyone with red-flag symptoms - blood in the stool, unintended weight loss, anemia, trouble swallowing, or symptoms that wake you at night - which warrant prompt evaluation, not self-treatment
- People who haven't addressed diet quality at all - clearing the field is wasted if the conditions that grew the overgrowth remain unchanged
The mechanism
An ecosystem, not a tube
The healthy gut wall is a layered barrier. The lining itself - the mucosa - is a single-cell-thick epithelium held together by tight-junction proteins and covered by a mucus coat that hosts the commensal (resident, beneficial) microbes. Beneath it sits the gut-associated lymphoid tissue (GALT), the largest immune organ in the body. These parts are in constant conversation with the luminal contents - food, microbes, and their metabolites - passing through.
Dysbiosis is the disruption of that microbial balance. Overgrowth of opportunistic bacteria, yeast, or parasites; depletion of protective commensals; and the migration of colonic bacteria up into the small intestine (SIBO) are different expressions of one underlying failure: the ecosystem has lost its self-regulating capacity.
The consequences are not confined to the gut. Lipopolysaccharide (LPS) - a component of the outer membrane of gram-negative bacteria - is endotoxic. When the barrier loosens and permeability rises, LPS crosses into the bloodstream and drives a chronic low-grade inflammatory state that reaches the brain through both vagal signaling and circulation. This is the leading proposed link between gut dysbiosis and systemic inflammation, stress-axis dysregulation, insulin resistance, and the mood and cognitive symptoms that travel with them. In humans the endotoxin-to-brain pathway is well-established as a correlation and still being worked out as a cause.
Why two phases
Clearing the overgrowth and rebuilding the mucosa are distinct biological jobs. They need different tools and cannot be done at full effect at the same time. Adding probiotics and repair agents while a significant overgrowth is still active is like reseeding a lawn before pulling the weeds - in a disrupted environment, the entrenched organisms outcompete the ones you are trying to introduce. Phase 1 clears the field. Phase 2 rebuilds it.
The audit
Characterize your pattern
Before beginning, read your own symptoms precisely. The location, timing, and character of GI symptoms point to different mechanisms and different entry points in the protocol.
Location
Bloating high under the ribs, tight and pressurized, suggests upper-GI involvement - stomach, small intestine, or SIBO. Bloating low in the abdomen, gassy and gurgling, points to the large intestine. Both together suggest full-column dysbiosis.
Timing
Symptoms that build progressively across the day - fine in the morning, distended by evening - are a SIBO pattern: fermentation accumulates as food moves through a colonized small intestine. Symptoms immediate after eating point to the upper GI or significant food reactivity. Symptoms 2-4 hours post-meal suggest small-intestinal transit.
Bowel pattern
Hydrogen-dominant SIBO tends toward diarrhea. Methane-dominant - technically intestinal methanogen overgrowth, or IMO - tends toward constipation. Mixed patterns suggest both. A hydrogen-sulfide pattern (sulfur-egg burping, reactions to sulfur-rich foods) is a third variant. This distinction drives the antimicrobial selection in Phase 1.
Systemic symptoms
Brain fog that tracks with GI symptoms, mood shifts after meals, skin flares that follow dietary changes, joint pain or fatigue that worsens after eating - all point toward the systemic inflammatory and permeability component. These are as diagnostically relevant as the GI symptoms themselves.
If you want objective confirmation before beginning, the SIBO breath test is the most accessible tool - and the subtype it reveals is what steers treatment.
A comprehensive stool panel (for example, the GI-MAP) adds a view of the colonic microbiome, pathogen load, permeability markers, and digestive-enzyme output. Neither test is required to begin - but both let you weight the intervention more precisely.
Testing worth considering
This is not an exhaustive list - it is a core set that lets the gut picture be read alongside the systemic one. Your clinician may add to it based on your history.
The toolkit
Six jobs, six kinds of tool
The protocol reaches for several categories of intervention, and it helps to keep them straight - each does a different job, and blurring them is how people end up taking the wrong thing at the wrong time. These are not interchangeable. They are separate arms of one plan.
Step one
Lifestyle scaffolding
The protocol addresses the microbial and mucosal fronts directly. These foundations are what determine whether the gains hold after it ends. Build them first.
Diet during the protocol
A low-fermentable-carbohydrate approach during Phase 1 reduces the substrate available to the organisms being cleared and eases symptoms at the same time. This does not mean zero carbohydrate - it means minimizing the fermentable fibers (FODMAPs), refined sugars, and alcohol that preferentially feed dysbiotic organisms. Well-cooked vegetables, quality proteins, and fats are well tolerated by most people during active antimicrobial treatment. Reintroduce diverse plant fiber progressively during Phase 2 as the repair proceeds - fiber feeds the commensal bacteria you are reintroducing.
Stress and motility
The enteric nervous system - the gut's own neural network - governs motility, and the vagus nerve connects it directly to the brain. Chronic stress suppresses the migrating motor complex (MMC), the contractile wave that sweeps the small intestine between meals and prevents bacterial stagnation. This is one of the main ways chronic psychological stress produces or perpetuates SIBO. Deliberate down-regulation - slow breathing, non-sleep deep rest (NSDR), adequate sleep - is not a soft add-on here. It addresses a direct driver of the condition.
Meal spacing
The MMC only runs in a fasted state - it needs roughly 4-5 hours between meals to complete a full sweep. Continuous grazing prevents that and lets bacterial populations accumulate between meals. Three meals with adequate spacing, rather than frequent small ones, supports motility and reduces the fermentation burden in the small intestine. This runs counter to the usual advice for GI symptoms but is mechanistically correct for SIBO.
The sequence
Clear the field, then rebuild it
The two phases are a sequence, not a menu. Phase 1 runs the kill work - antimicrobials to reduce the overgrowth, a binder to escort the debris out, immunoglobulins for passive cover. Phase 2 runs the repair - mucosal healing, motility support, and the reintroduction of commensal species. The antimicrobials must be discontinued before the probiotic reintroduction begins, or you will be clearing the very organisms you are trying to establish.
Phase 1 · 4-6 weeks
The kill phase
The goal of Phase 1 is to reduce the overgrowth, contain the inflammatory load from dying organisms (die-off), and prepare the environment for repair. The binder is the critical first move - it has to be taken separately from everything else, or it binds your other supplements rather than the toxins.
Binder - take separately from all other supplements
Activated charcoal and bentonite clay bind endotoxins, mycotoxins, and the cellular debris released by dying organisms - carrying them out of the GI tract before they can be reabsorbed and trigger systemic reactions. Take at least 30 minutes before other supplements or medications, and do not eat for 60 minutes afterward. This timing is non-negotiable: a binder cannot tell vitamins from toxins, and will bind whatever is nearby.
Quicksilver Scientific
Antimicrobials - the clearance arm
A liposomal blend of botanical antimicrobials - including oregano, berberine, and quercetin - in a phospholipid carrier that improves tissue penetration over capsules. The liposomal carrier aims to improve mucosal contact and help the botanicals penetrate the biofilm where dysbiotic organisms shelter; the 90-second sublingual hold before swallowing is part of that delivery. Biocidin is broad-spectrum - active across gram-positive and gram-negative bacteria, yeast, and biofilm-forming organisms. Biofilm disruption matters here: many dysbiotic organisms shelter in biofilm communities that plainer antimicrobials do not penetrate.
Bio-Botanical Research
Cat's claw (Uncaria tomentosa) is an anti-inflammatory and antimicrobial botanical with preliminary evidence for biofilm disruption and immune modulation in the gut. The liposomal liquid delivery aims to improve tissue penetration over capsule forms; held under the tongue 30 seconds before swallowing. Taken in the evening as the complement to the morning Biocidin dose, it extends antimicrobial coverage across the full day and supports the anti-inflammatory work alongside the clearance.
Quicksilver Scientific
Carvacrol and thymol - the primary bioactives in oregano oil - have well-documented broad-spectrum antimicrobial and antifungal activity, and are particularly active against Candida species and gram-positive organisms. The softgel form aims to deliver the actives to the small intestine rather than releasing them in the stomach - the target site for SIBO. With or without food.
Oleuropein, the primary bioactive in olive leaf, has antimicrobial activity against a range of pathogens and adds antifungal coverage complementary to oregano oil. It also carries anti-inflammatory and antioxidant properties that can ease the inflammatory burden of the kill phase. With or without food.
Saccharomyces boulardii is a non-pathogenic yeast probiotic with well-documented antagonism toward Candida albicans, C. difficile, and a range of enteric bacterial pathogens. Because it is a yeast, not a bacterium, it is unaffected by the antimicrobials above - a unique adjunct during the kill phase, stabilizing the mucosal environment while the broader microbial population is reduced. S. boulardii also supports secretory IgA at the gut wall. Carries into Phase 2 alongside the immunoglobulin support until the bacterial reintroduction is established.
Designs for Health
Serum-derived bovine immunoglobulins (IgG, IgA, IgM) that bind and neutralize bacteria, bacterial toxins, and LPS in the gut lumen - passive immune cover at the mucosal surface while the clearance is underway. This is a distinct arm from the antimicrobials: it does not kill, it binds. IgGI Shield carries into Phase 2, because the immune-support role is as relevant during repair as during clearance. Mix in a smoothie or take on an empty stomach.
Systemic Formulas
Phase 1 adjuncts - symptom-specific, not a bundle
The products above form the universal Phase 1 stack. The following are added when a specific symptom pattern or panel finding warrants - considered individually, one at a time.
A broad-spectrum digestive enzyme blend (amylase, protease, lipase, lactase, alpha-galactosidase, cellulase, hemicellulase, xylanase). Added when pancreatic elastase is borderline-low, when PPI use is suppressing upstream gastric acid, or when the picture includes early satiety, fullness with small portions, and incomplete digestion. It works the digestion step that comes before the microbial one - if food reaches the small intestine incompletely broken down, fermentation by the organisms present is greater than it should be. Continues through Phase 2 as long as the digestive insufficiency persists.
Enzyme Science
A motility-support blend of ginger root, artichoke leaf, acetyl-L-carnitine, and 5-HTP that targets the migrating motor complex (MMC) - the wave that sweeps the small intestine between meals and is the main mechanism preventing bacterial stagnation. When motility is impaired - methane-dominant SIBO, constipation-dominant patterns, evening-worse bloating, a history of recurrence - supporting the MMC while antimicrobials reduce the burden is one of the more important determinants of whether the gains hold. This is the prokinetic arm, distinct from the kill work. Take 10 minutes before bed to support the overnight sweep, and between meals during the day.
Pure Encapsulations
Despite "Phase-2" in the product name (the manufacturer's internal naming for their biofilm protocol), this is a Phase 1 clearance product by mechanism. It contains bismuth subnitrate, which binds hydrogen sulfide and adds antimicrobial coverage; alpha-lipoic acid, which aims to disrupt the biofilm matrix and modulate sulfide pathways; and Nigella sativa (black cumin) for broad antimicrobial activity. Indicated when a stool test shows elevated Desulfovibrio, when an H2S-pattern SIBO is suspected (sulfur-egg burping, reactions to sulfur-rich foods), or when biofilm-protected overgrowth is likely. Separate from the binder by 30-60 minutes.
Priority One
Enteric-coated peppermint oil with RCT-tier evidence for IBS pain and functional dyspepsia. The enteric coating is non-negotiable here: non-enteric peppermint oil relaxes the lower esophageal sphincter and worsens reflux - the opposite of the intent in a reflux-pattern picture. The coating delivers the actives to the small intestine, where the antispasmodic and carminative effects address the visceral hypersensitivity and post-meal distension that characterize functional dyspepsia. Continues through Phase 2 as long as epigastric pain, early satiety, or post-meal distension persist.
Nature's Way
The same product described in Phase 2, with a Phase 1 role as well: its polysaccharide content provides anti-inflammatory mucosal cover during the die-off period, when dying organisms release LPS and debris the binder cannot fully catch. Particularly useful when calprotectin is elevated or the picture includes significant mucosal inflammation alongside the dysbiosis. Carries through Phase 2.
Designs for Health
Phase 2 · 4-8 weeks
The repair phase
With the overgrowth managed, Phase 2 addresses the structural damage: tight-junction repair, mucosal regeneration, and reintroduction of the commensal bacteria a healthy gut requires. Do not rush the transition - the Phase 1 antimicrobials should be discontinued before the probiotic reintroduction begins.
Mucosal repair - heal the lining
This kit covers the immunoglobulin, prebiotic, and probiotic arms of the protocol in one coordinated system.
- MegaIgG2000 - a serum-derived bovine immunoglobulin concentrate (IgG, IgA, IgM) that binds and neutralizes bacteria, bacterial toxins, and LPS in the gut lumen. This is the immunoglobulin arm - the IgGI Shield equivalent - carrying passive mucosal cover through both phases.
- MegaPre - a precision prebiotic fiber blend (Bimuno galactooligosaccharides, PreticX xylooligosaccharides, organic kiwifruit). These are selected to preferentially feed Lactobacillus and Bifidobacterium rather than the whole population indiscriminately - in a post-dysbiosis gut, you want to feed the organisms you are establishing, not the residual opportunists.
- MegaSporeBiotic - a spore-based probiotic of five Bacillus strains. The endospore coat protects them through gastric acid and bile, so a high fraction survives to the small intestine where colonization occurs. In a just-cleared environment, that survivability is the variable that decides whether the introduced organisms actually establish.
Microbiome Labs
A comprehensive mucosal-repair formula built around L-glutamine, slippery elm, deglycyrrhizinated licorice (DGL), aloe vera, and arabinogalactan. L-glutamine is the primary fuel for enterocytes - the cells lining the intestinal wall - and the rate-limiting substrate for mucosal regeneration. Slippery elm and DGL provide demulcent, soothing mucosal protection. Arabinogalactan acts as a prebiotic, feeding the commensals being reintroduced. This is the mucosal-support arm, working repair from several angles at once.
At therapeutic doses for mucosal repair - meaningfully higher than a blended formula alone provides - L-glutamine fuels enterocyte proliferation and tight-junction protein synthesis. The intestinal epithelium turns over completely every 3-5 days; adequate glutamine is what lets that regeneration happen at pace. Divide across 2-3 doses through the day for sustained availability. With or without food.
A concentrated aloe vera extract (500 mg Aloe barbadensis at 200:1 per capsule) that soothes mucosal inflammation and supports epithelial regeneration through its polysaccharide content. Particularly useful when the mucosal picture has a significant inflammatory component alongside the permeability.
Designs for Health
Emulsified vitamin A (retinyl palmitate), roughly 3000 mcg per drop. Vitamin A is a key regulator of intestinal immune function and epithelial cell differentiation - without adequate vitamin A, the tight-junction proteins that seal the barrier cannot be synthesized at the required rate. The emulsion form absorbs better than capsule retinyl palmitate, which matters given the fat malabsorption that often accompanies significant dysbiosis. Do not exceed the stated dose - vitamin A can be toxic at high long-term intakes, so keep this to the single-drop dose and skip it if you are or may become pregnant. With or without food.
Seroyal / Genestra
Body-protective compound 157 is a synthetic peptide fragment of a protein found in gastric juice, with gut-healing and anti-inflammatory effects demonstrated largely in animal models and early, limited human research - so treat the benefit as plausible but not yet well-established. The delayed-release format is mechanistically relevant: it aims to bypass gastric-acid degradation and release in the small intestine where the repair target sits. BPC-157 is a research peptide with evolving and uncertain regulatory status - discuss it with your clinician before adding, rather than treating it as a settled part of the stack.
InfiniWell
Microbial reintroduction - reseed the flora
Discussed above as part of the Total Gut Restoration Kit. The spore-based format is the point for post-dysbiosis reseeding: the endospore coat survives acid and bile, so a high fraction reaches the small intestine intact. Start at one capsule with meals and increase after two weeks. This is the probiotic arm.
Microbiome Labs
Akkermansia muciniphila is the organism most consistently and inversely correlated with intestinal permeability, metabolic syndrome, and inflammatory bowel conditions in human data. It colonizes the mucus layer specifically and produces short-chain fatty acids that feed colonocytes and reinforce the barrier. The human RCT improvements (gut-barrier integrity, insulin sensitivity, inflammatory markers) are specifically for the pasteurized form; live-cell products like this one rest on the same rationale but have not matched those metabolic outcomes in trials. It still earns a place for restoring a species that thins in dysbiosis - just hold the metabolic claims to the pasteurized evidence.
CodeAge
Phase 2 adjuncts - fiber and polyphenol restoration
A multi-substrate fiber blend: Sunfiber PHGG (partially hydrolyzed guar gum, the component with RCT evidence for IBS-C and normalized transit), PreticX xylooligosaccharides, glucomannan, flax fiber, prune powder, apple pectin, and magnesium citrate. The variety is the point - a recovering post-dysbiosis gut needs gradual reintroduction of multiple substrate classes to rebuild diversity. The magnesium citrate additionally supports transit during the early Phase 2 weeks while the prokinetic supports are still establishing the pattern. Ramp the dose to avoid an initial fermentation burden in a gut that may still be sensitive.
Pure Encapsulations
Pomegranate ellagitannins are the substrate from which gut bacteria produce urolithin A, a metabolite with early evidence for mitochondrial function and Akkermansia support. The polyphenol approach is mechanistically distinct from the prebiotic-fiber one: instead of feeding bacteria in the lumen, ellagitannin metabolites support the mucus-layer environment where Akkermansia colonizes. Because only some people (roughly 40%) convert ellagitannins to urolithin A efficiently, a polyphenol substrate has broader applicability than a finished-metabolite product - though the individual response varies. Particularly indicated when Akkermansia is depleted on stool testing or barrier markers are elevated.
Life Extension (Pomella)
The bottom line
Clear, then rebuild
The two-phase structure is not optional - it is the mechanistic sequence. Clearing without rebuilding leaves an emptied environment that opportunists repopulate faster than commensals can establish. Rebuilding without clearing first means fighting an entrenched community with your hands tied. Do both, in order, with the timing the protocol specifies.
The lifestyle variables - diet during the protocol, meal spacing, stress, sleep - are not soft additions. They address the motility, mucosal immunity, and dietary environment that let the dysbiosis establish in the first place. Without them, the protocol works and then reverses. With them, the gains hold.
Weed before you seed. Then seed what you weeded for. The order is the medicine.
Appendix
When to bring in a clinician
A self-directed protocol has a ceiling. If it produces meaningful improvement and then plateaus, or if symptoms recur within weeks of finishing Phase 2, the picture has moved past what this guide can reach on its own. The usual culprits are worth knowing - and testing and clinical oversight are what close the gap from here.
- An unaddressed upstream driver - chronic stress that keeps the migrating motor complex suppressed, ongoing NSAID or PPI use, or hypothyroidism slowing motility. The overgrowth returns because its cause was never removed.
- A diet still refeeding the overgrowth - if the fermentable-substrate load never came down, the clearance was always going to be temporary.
- A comorbid condition - SIBO from ileocecal-valve dysfunction, fungal overgrowth needing a different antimicrobial approach, or a structural issue - that warrants clinical evaluation rather than another round of the same protocol.
- Any red-flag symptom that has appeared or persisted - blood in the stool, unintended weight loss, anemia, difficulty swallowing, or symptoms that wake you at night - which moves this out of self-management entirely and into prompt medical evaluation.
This is the point at which a breath test, a stool panel, and a clinician's eyes on the whole picture do what a self-directed protocol cannot. Bring the audit and the testing to that visit - they make the conversation far more precise.
This guide is educational and is not medical advice, diagnosis, or treatment. It does not replace the judgment of a licensed clinician who knows your history and your labs. Antimicrobial protocols, research peptides, and related interventions carry real risks and can interact with medications and existing conditions - review any protocol with your clinician before starting, particularly if you are pregnant, managing a medical condition, or taking prescription medication. Red-flag symptoms - blood in the stool, unintended weight loss, anemia, difficulty swallowing, or symptoms that wake you from sleep - warrant prompt medical evaluation, not self-treatment. The testing and supplement panels listed here are illustrative, not exhaustive.